Mark G. Lewis
Mark G. Lewis publishes mostly in Infectious Diseases, Immunology and Virology, on topics such as HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research and Immune Cell Function and Interaction.
- World rank
- #86,691 of 7,710,434 ranked researchers
- Rank in United States
- #33,499 of 1,627,098
- Works
- 369
- Citations
- 45k
- Citations per work
- 122.1
What does Mark G. Lewis research?
Mark G. Lewis's work is mostly in Immunology and Microbiology (39%), Medicine (36%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences17447.1%
- Health Sciences13235.9%
- Medicine13235.9%
- Everything else6317.0%
- 1Infectious Diseases26% of their works
- 2Immunology21% of their works
- 3Virology18% of their works
- 4Epidemiology10% of their works
- 5Molecular Biology5% of their works
- 6Genetics3% of their works
Research topics
Which keywords describe Mark G. Lewis's research?
The keywords of their largest research topics: Vaccine, Immune Response, Antiretroviral Therapy, AIDS, HIV, Immunity, ACE2 Receptor and SARS-CoV-2.
- Viral Vectors
- Preexposure Prophylaxis
- TGF-ß
- Epidemiology
- Dendritic Cells
- Natural Killer Cells
- spike protein
- SARS-CoV-2
- Immunity
- AIDS
- Immune Response
- Vaccine
- Antiretroviral Therapy
- HIV
- ACE2 Receptor
- Coronavirus
- NK Cell Recognition
- Cancer Immunotherapy
- Clinical Characteristics
- Foxp3
- HIV Transmission
- Gene Therapy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Vaccine2872 topics
- Immune Response2372 topics
- Antiretroviral Therapy2192 topics
- AIDS1821 topic
- HIV1821 topic
- Immunity1652 topics
- ACE2 Receptor1602 topics
- SARS-CoV-21602 topics
- Coronavirus1051 topic
- spike protein1051 topic
- NK Cell Recognition841 topic
- Natural Killer Cells841 topic
- Cancer Immunotherapy601 topic
- Dendritic Cells601 topic
- Clinical Characteristics551 topic
- Epidemiology551 topic
- Foxp3521 topic
- TGF-ß521 topic
- HIV Transmission371 topic
- Preexposure Prophylaxis371 topic
- Gene Therapy301 topic
- Viral Vectors301 topic
Where does Mark G. Lewis work?
Mark G. Lewis's main affiliation in the publication record is Bioqual, United States.
How many publications and citations does Mark G. Lewis have?
OpenAlex counts 369 works and 45,064 citations for Mark G. Lewis, an h-index of 79, ranking #86,691 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark G. Lewis. Posts are plain text and can be reported.